This page lists the SEC filings reported by GSA CAPITAL PARTNERS LLP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-01-02 | GSA CAPITAL PARTNERS LLP | Galera Therapeutics, Inc. | 3,892,561 | 7.2% | EDGAR |
| SC 13G | 2023-07-31 | GSA CAPITAL PARTNERS LLP | T2 Biosystems, Inc. | 4,599,059 | 1.5% | EDGAR |
| SC 13G | 2023-06-30 | GSA CAPITAL PARTNERS LLP | T2 Biosystems, Inc. | 3,799,487 | 15.2% | EDGAR |
| SC 13G | 2023-06-21 | GSA CAPITAL PARTNERS LLP | T2 Biosystems, Inc. | 24,887,722 | 10.7% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.